triiodothyronine has been researched along with Acute Liver Injury, Drug-Induced in 41 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient with primary hypothyroidism, who developed hepatocellular injury due to levothyroxine, synthetic thyroxine." | 7.74 | Liver injury induced by levothyroxine in a patient with primary hypothyroidism. ( Aiso, M; Fukusato, T; Hojo, M; Ishii, T; Kawakami, T; Kawasaki, T; Kuyama, Y; Mikami, M; Morisawa, Y; Negoro, S; Takikawa, H; Tanaka, A; Uegaki, S; Yamamoto, T, 2007) |
| "Exposure of hyperthyroid rats to halothane results in a centrilobular necrosis of the liver and an 11-fold increase in serum glutamate-pyruvate transaminase (SGPT) levels." | 7.67 | Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats. ( Berman, ML; Harbison, RD; James, RC; Smith, AC, 1984) |
| "A series of experiments were conducted to examine the potential role of phase I metabolism in halothane-induced liver injury in the hyperthyroid rat." | 7.67 | Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat. ( Berman, LM; Harbison, RD; James, RC; Roberts, SM; Smith, AC, 1988) |
| "1% hexachlorobenzene (HCB) for 55 days on mortality, body weight, urinary porphyrin excretion, serum thyroid hormones and induction of liver microsomal enzymes was studied in female Sprague-Dawley rats." | 7.67 | Reduced serum thyroid hormone levels in hexachlorobenzene-induced porphyria. ( Gorski, JR; Parkinson, A; Rozman, K; Rozman, P, 1986) |
| "Administration of anesthetic doses of halothane to hyperthyroid male rats results in the development of hepatic necrosis." | 7.66 | Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity. ( Berman, ML; Harbison, RD; James, RC; Smith, AC, 1983) |
| "8% enflurane, or 1% halothane in 21% oxygen (air) for two hours resulted in hepatic centrilobular necrosis." | 7.66 | Isoflurane and enflurane-induced hepatic necrosis in triiodothyronine-pretreated rats. ( Berman, ML; Holaday, DA; Kuhnert, L; Phythyon, JM, 1983) |
| "Factors affecting halothane (H) hepatotoxicity were investigated in two animal models: 1) the phenobarbital-hypoxia model, and 2) the triiodothyronine (T3) model; in the latter we previously have shown that centrilobular necrosis occurs in T3 pretreated rats anesthetized with 1% H, in 21% oxygen for 2 h." | 7.66 | Contrasting effects on halothane hepatotoxicity in the phenobarbital-hypoxia and triiodothyronine model: mechanistic implications. ( Phythyon, JM; Uetrecht, J; Wood, AJ; Wood, M, 1983) |
| "Hepatic centrilobular necrosis developed in rats pretreated with triiodothyronine (T3) and then anesthetized with halothane, 1 per cent, for two hours at an ambient oxygen concentration." | 7.66 | Halothane-induced hepatic necrosis in triiodothyronine-pretreated rats. ( Berman, ML; Harbison, RD; Hoyle, P; Phythyon, JM; Wood, AJ; Wood, M, 1980) |
| "Quercetin is a plant flavonoid and has antioxidative properties." | 5.56 | Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway. ( Hou, Q; Hu, Z; Ma, W; Tian, Z; Zang, L; Zhao, P, 2020) |
| "Plethoryl is a combination of triatricol, cyclovalone and vitamin A normally prescribed in the treatment of hypercholesterolaemia." | 5.28 | [Probable side effects caused by plethoryl. Common acute hepatitis, anicteric hepatitis, cirrhosis due to hypervitaminosis A, inflammatory arthralgias]. ( Constantin, JM; Maroy, B; Moullot, P, 1989) |
| "Levothyroxine is a synthetic thyroxine and is the treatment of choice for hypothyroidism." | 3.91 | Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report. ( Al-Khairalla, MZH; Hlaihel, AF, 2019) |
| "We report a patient with primary hypothyroidism, who developed hepatocellular injury due to levothyroxine, synthetic thyroxine." | 3.74 | Liver injury induced by levothyroxine in a patient with primary hypothyroidism. ( Aiso, M; Fukusato, T; Hojo, M; Ishii, T; Kawakami, T; Kawasaki, T; Kuyama, Y; Mikami, M; Morisawa, Y; Negoro, S; Takikawa, H; Tanaka, A; Uegaki, S; Yamamoto, T, 2007) |
| "Exposure of hyperthyroid rats to halothane results in a centrilobular necrosis of the liver and an 11-fold increase in serum glutamate-pyruvate transaminase (SGPT) levels." | 3.67 | Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats. ( Berman, ML; Harbison, RD; James, RC; Smith, AC, 1984) |
| "A series of experiments were conducted to examine the potential role of phase I metabolism in halothane-induced liver injury in the hyperthyroid rat." | 3.67 | Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat. ( Berman, LM; Harbison, RD; James, RC; Roberts, SM; Smith, AC, 1988) |
| "1% hexachlorobenzene (HCB) for 55 days on mortality, body weight, urinary porphyrin excretion, serum thyroid hormones and induction of liver microsomal enzymes was studied in female Sprague-Dawley rats." | 3.67 | Reduced serum thyroid hormone levels in hexachlorobenzene-induced porphyria. ( Gorski, JR; Parkinson, A; Rozman, K; Rozman, P, 1986) |
| "Administration of anesthetic doses of halothane to hyperthyroid male rats results in the development of hepatic necrosis." | 3.66 | Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity. ( Berman, ML; Harbison, RD; James, RC; Smith, AC, 1983) |
| "8% enflurane, or 1% halothane in 21% oxygen (air) for two hours resulted in hepatic centrilobular necrosis." | 3.66 | Isoflurane and enflurane-induced hepatic necrosis in triiodothyronine-pretreated rats. ( Berman, ML; Holaday, DA; Kuhnert, L; Phythyon, JM, 1983) |
| "Factors affecting halothane (H) hepatotoxicity were investigated in two animal models: 1) the phenobarbital-hypoxia model, and 2) the triiodothyronine (T3) model; in the latter we previously have shown that centrilobular necrosis occurs in T3 pretreated rats anesthetized with 1% H, in 21% oxygen for 2 h." | 3.66 | Contrasting effects on halothane hepatotoxicity in the phenobarbital-hypoxia and triiodothyronine model: mechanistic implications. ( Phythyon, JM; Uetrecht, J; Wood, AJ; Wood, M, 1983) |
| "Hepatic centrilobular necrosis developed in rats pretreated with triiodothyronine (T3) and then anesthetized with halothane, 1 per cent, for two hours at an ambient oxygen concentration." | 3.66 | Halothane-induced hepatic necrosis in triiodothyronine-pretreated rats. ( Berman, ML; Harbison, RD; Hoyle, P; Phythyon, JM; Wood, AJ; Wood, M, 1980) |
| "Quercetin is a plant flavonoid and has antioxidative properties." | 1.56 | Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway. ( Hou, Q; Hu, Z; Ma, W; Tian, Z; Zang, L; Zhao, P, 2020) |
| " Therefore, it is necessary to assess the toxic effects of those kind of industrial chemicals during liver development." | 1.51 | Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations. ( Faiola, F; Liang, S; Yin, N, 2019) |
| "Recent work has demonstrated the importance of post-transcriptional gene regulation in toxic responses." | 1.39 | Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity. ( Darras, VM; Dudek, KM; Gant, TW; Marczylo, EL; Suter, L, 2013) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| " An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems." | 1.36 | Developing structure-activity relationships for the prediction of hepatotoxicity. ( Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010) |
| " It is concluded that hyperthyroidism increases the susceptibility of the liver to the toxic effects of lindane, which seems to be accomplished by potentiation of the hepatic oxidative stress status." | 1.29 | Influence of hyperthyroidism on lindane-induced hepatotoxicity in the rat. ( Fernández, V; Junqueira, VB; Simon, KA; Smok, G; Troncoso, P; Videla, LA, 1995) |
| "Plethoryl is a combination of triatricol, cyclovalone and vitamin A normally prescribed in the treatment of hypercholesterolaemia." | 1.28 | [Probable side effects caused by plethoryl. Common acute hepatitis, anicteric hepatitis, cirrhosis due to hypervitaminosis A, inflammatory arthralgias]. ( Constantin, JM; Maroy, B; Moullot, P, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (48.78) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 4 (9.76) | 29.6817 |
| 2010's | 13 (31.71) | 24.3611 |
| 2020's | 2 (4.88) | 2.80 |
| Authors | Studies |
|---|---|
| Fourches, D | 1 |
| Barnes, JC | 1 |
| Day, NC | 1 |
| Bradley, P | 1 |
| Reed, JZ | 1 |
| Tropsha, A | 1 |
| Greene, N | 1 |
| Fisk, L | 1 |
| Naven, RT | 1 |
| Note, RR | 1 |
| Patel, ML | 1 |
| Pelletier, DJ | 1 |
| Ekins, S | 1 |
| Williams, AJ | 1 |
| Xu, JJ | 1 |
| Chen, M | 2 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 3 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Aleo, MD | 1 |
| Luo, Y | 1 |
| Swiss, R | 1 |
| Bonin, PD | 1 |
| Potter, DM | 1 |
| Will, Y | 1 |
| Suzuki, A | 1 |
| Thakkar, S | 1 |
| Yu, K | 1 |
| Hu, C | 1 |
| Liu, K | 1 |
| Chen, X | 1 |
| Ren, Y | 1 |
| Liu, C | 1 |
| Zhang, J | 2 |
| Wang, Z | 1 |
| Li, Y | 1 |
| Zhang, Y | 1 |
| Hlaihel, AF | 1 |
| Al-Khairalla, MZH | 1 |
| Zhao, P | 1 |
| Hu, Z | 1 |
| Ma, W | 1 |
| Zang, L | 1 |
| Tian, Z | 1 |
| Hou, Q | 1 |
| Liang, S | 2 |
| Yin, N | 1 |
| Faiola, F | 1 |
| Dudek, KM | 1 |
| Suter, L | 1 |
| Darras, VM | 1 |
| Marczylo, EL | 1 |
| Gant, TW | 1 |
| Warner, JV | 1 |
| Morton, AP | 1 |
| Hall, AJ | 1 |
| Henman, MG | 1 |
| Pool, LF | 1 |
| Yang, J | 1 |
| Li, LF | 1 |
| Xu, Q | 1 |
| Weng, WW | 1 |
| Zhu, YJ | 1 |
| Dong, MJ | 1 |
| Simon-Giavarotti, KA | 1 |
| Giavarotti, L | 1 |
| Gomes, LF | 1 |
| Lima, AF | 1 |
| Veridiano, AM | 1 |
| Garcia, EA | 1 |
| Mora, OA | 1 |
| Fernández, V | 2 |
| Videla, LA | 2 |
| Junqueira, VB | 2 |
| Briukhin, GV | 1 |
| Nikolina, OV | 1 |
| Barysheva, SV | 1 |
| Swarup, D | 1 |
| Naresh, R | 1 |
| Varshney, VP | 1 |
| Balagangatharathilagar, M | 1 |
| Kumar, P | 1 |
| Nandi, D | 1 |
| Patra, RC | 1 |
| Kawakami, T | 1 |
| Tanaka, A | 1 |
| Negoro, S | 1 |
| Morisawa, Y | 1 |
| Mikami, M | 1 |
| Hojo, M | 1 |
| Yamamoto, T | 1 |
| Uegaki, S | 1 |
| Aiso, M | 1 |
| Kawasaki, T | 1 |
| Ishii, T | 1 |
| Kuyama, Y | 1 |
| Fukusato, T | 1 |
| Takikawa, H | 1 |
| Danan, G | 1 |
| Pessayre, D | 2 |
| Rueff, B | 1 |
| Benhamou, JP | 2 |
| Smith, AC | 4 |
| Berman, ML | 4 |
| James, RC | 4 |
| Harbison, RD | 5 |
| Kuhnert, L | 1 |
| Phythyon, JM | 3 |
| Holaday, DA | 1 |
| Uetrecht, J | 1 |
| Wood, AJ | 2 |
| Wood, M | 2 |
| Iwaoka, T | 1 |
| Umeda, T | 1 |
| Nakayama, M | 1 |
| Shimada, T | 1 |
| Fujii, Y | 1 |
| Miura, F | 1 |
| Sato, T | 1 |
| Peterson, ME | 1 |
| Hoyle, P | 1 |
| Smok, G | 1 |
| Troncoso, P | 1 |
| Simon, KA | 1 |
| Yamagishi, F | 1 |
| Komoda, T | 1 |
| Ohnishi, K | 1 |
| Itoh, S | 1 |
| Bleich, HL | 1 |
| Boro, ES | 1 |
| Maroy, B | 1 |
| Moullot, P | 1 |
| Constantin, JM | 1 |
| Causse, X | 1 |
| Paliard, P | 1 |
| Tran-Thi, TA | 1 |
| Phillips, J | 1 |
| Falk, H | 1 |
| Decker, K | 1 |
| Roberts, SM | 2 |
| Berman, LM | 2 |
| Larrey, D | 1 |
| Fréneaux, E | 1 |
| Babany, G | 1 |
| Berson, A | 1 |
| Amédée-Manesme, O | 1 |
| Degott, C | 2 |
| Bettan, L | 1 |
| Paugam, B | 1 |
| Gelman, S | 1 |
| Atttali, P | 1 |
| Bernuau, J | 1 |
| Fabre, M | 1 |
| Ink, O | 1 |
| Marti, R | 1 |
| Voiment, YM | 1 |
| André, JM | 1 |
| Rozman, K | 1 |
| Gorski, JR | 1 |
| Rozman, P | 1 |
| Parkinson, A | 1 |
| Ruiz-Torres, A | 1 |
1 review available for triiodothyronine and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
40 other studies available for triiodothyronine and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2014 |
3,3',5-triiodo-l-thyronine inhibits drug-induced liver injury through activation of PPARα as revealed by network pharmacology and biological experimental verification.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Failure, Acute; Network | 2022 |
Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report.
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Hormone Replacement Therapy; Humans; Hypothyr | 2019 |
Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway.
Topics: Animals; Antioxidants; Body Weight; Catalase; Chemical and Drug Induced Liver Injury; Eating; Gene E | 2020 |
Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations.
Topics: Animals; Cell Differentiation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, D | 2019 |
Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Gene Expression Regulation; Iodide Peroxidase; Live | 2013 |
Internet slimming, thyrotoxicosis and the liver.
Topics: Adult; Appetite Depressants; Chemical and Drug Induced Liver Injury; China; Cyclobutanes; Drug Combi | 2014 |
Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Topics: Adult; Aged; Antithyroid Agents; Chemical and Drug Induced Liver Injury; China; Female; Graves Disea | 2015 |
Enhancement of lindane-induced liver oxidative stress and hepatotoxicity by thyroid hormone is reduced by gadolinium chloride.
Topics: Animals; Catalase; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Energy Me | 2002 |
[Morphological and functional characteristics of thyroid gland in the offspring of female rats with experimental chronic liver disease of various etiology].
Topics: Animals; Animals, Newborn; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; C | 2005 |
Changes in plasma hormones profile and liver function in cows naturally exposed to lead and cadmium around different industrial areas.
Topics: Animals; Cadmium; Cattle; Chemical and Drug Induced Liver Injury; Environmental Exposure; Environmen | 2007 |
Liver injury induced by levothyroxine in a patient with primary hypothyroidism.
Topics: Chemical and Drug Induced Liver Injury; Humans; Hypothyroidism; Liver Diseases; Male; Middle Aged; T | 2007 |
[Acute hepatitis probably due to Plethoryl].
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Drug Combin | 1984 |
Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.
Topics: Alanine Transaminase; Animals; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Inj | 1983 |
Paradoxical effects of perturbation of intracellular levels of glutathione on halothane-induced hepatotoxicity in hyperthyroid rats.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Glutathione; | 1984 |
Isoflurane and enflurane-induced hepatic necrosis in triiodothyronine-pretreated rats.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Eating; Enflurane; Halothane; Hyperthy | 1983 |
Contrasting effects on halothane hepatotoxicity in the phenobarbital-hypoxia and triiodothyronine model: mechanistic implications.
Topics: Animals; Chemical and Drug Induced Liver Injury; Fasting; Fluorides; Halothane; Hypoxia; Liver Disea | 1983 |
A case of membranous nephropathy associated with thyroid antigens.
Topics: Antigens; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Humans; Hypothyroidism; I | 1982 |
Propylthiouracil in the treatment of feline hyperthyroidism.
Topics: Administration, Oral; Animals; Cat Diseases; Cats; Chemical and Drug Induced Liver Injury; Hyperthyr | 1981 |
Halothane-induced hepatic necrosis in triiodothyronine-pretreated rats.
Topics: Alanine Transaminase; Animals; Body Weight; Chemical and Drug Induced Liver Injury; Cytochrome P-450 | 1980 |
Influence of hyperthyroidism on lindane-induced hepatotoxicity in the rat.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; | 1995 |
Protective effect of dantrolene sodium on carbon tetrachloride induced liver injury in the rat.
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochr | 1993 |
Metabolic and hepatic effects of alcohol.
Topics: Acidosis; Alcohol Oxidoreductases; Alcoholism; Amino Acids; Animals; Carbohydrate Metabolism; Chemic | 1977 |
[Probable side effects caused by plethoryl. Common acute hepatitis, anicteric hepatitis, cirrhosis due to hypervitaminosis A, inflammatory arthralgias].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Cyclohexanes; | 1989 |
[Hepatitis with auto-immunization probably caused by Plethoryl].
Topics: Adult; Autoantibodies; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpe | 1989 |
Toxicity of D-galactosamine for rat hepatocytes in monolayer culture.
Topics: Albumins; Animals; Calcium; Calmodulin; Cell Membrane Permeability; Cell Survival; Cells, Cultured; | 1985 |
Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Glutathione; Halothane; Hyperthyroidism; Lipid Meta | 1988 |
[Hepatitis probably caused by Plethoryl. Apropos of 7 cases].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpen | 1988 |
Effects of piperonyl butoxide on halothane hepatotoxicity and metabolism in the hyperthyroid rat.
Topics: Administration, Inhalation; Animals; Chemical and Drug Induced Liver Injury; Chlorofluorocarbons; Cy | 1988 |
Halothane hepatotoxicity--again?
Topics: Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Guinea Pigs; Halothane; Humans; | 1986 |
[Fatal fulminant hepatitis probably due to Plethoryl].
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Drug Combin | 1986 |
[Acute hepatitis caused by Plethoryl].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Cyclohexanes; Cyclohexanones; Diterpenes; Dru | 1986 |
Reduced serum thyroid hormone levels in hexachlorobenzene-induced porphyria.
Topics: Administration, Oral; Animals; Body Weight; Chemical and Drug Induced Liver Injury; Chlorobenzenes; | 1986 |
[Dynamics of collagen during hepatic injury by carbon tetrachloride. Problem of the hormonal induction of collagen metabolism].
Topics: Animals; Bone and Bones; Carbon Isotopes; Carbon Tetrachloride Poisoning; Chemical and Drug Induced | 1971 |